Cargando…
The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis
OBJECTIVE: To systematically evaluate the effects of lead therapies on percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI). METHODS: A randomized controlled trial (RCT) in the CNKI, Wanfang, VIP, ProQuest, PubMed, Cochrane Library, Scopus, and Web of Science databases wa...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681617/ https://www.ncbi.nlm.nih.gov/pubmed/38013356 http://dx.doi.org/10.1097/MD.0000000000036183 |
_version_ | 1785150831369125888 |
---|---|
author | Sun, Meixia Ding, Yi Chen, Kang He, Yanwen Zhang, Yukun Zhuo, Yue Zhuang, He |
author_facet | Sun, Meixia Ding, Yi Chen, Kang He, Yanwen Zhang, Yukun Zhuo, Yue Zhuang, He |
author_sort | Sun, Meixia |
collection | PubMed |
description | OBJECTIVE: To systematically evaluate the effects of lead therapies on percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI). METHODS: A randomized controlled trial (RCT) in the CNKI, Wanfang, VIP, ProQuest, PubMed, Cochrane Library, Scopus, and Web of Science databases was searched until January 2023. Two researchers strictly screened and checked the included literature, extracted relevant data, and used the Cochrane Manual to assess the risk quality of the literature. Using RevMan 5.3 software, Meta-analysis of 4 main outcome measures [cardiac function-related indicators, 6-minute walking distance (6 MWT), quality of life (SF-36), Seattle angina pectoris scale (SAQ)], and 3 secondary outcome measures [adverse event incidence, death incidence, and readmission rate]. RESULTS: 22 studies were finally included with 1754 subjects, but the overall quality of the included studies was not high. The results of the meta-analysis showed that, in the cardiac function-related indicators compared to controls, improved left ventricular ejection fraction (LVEF) index (MD = 1.42, 95%CI [−0.94, 3.79], P < .00001); however, compared with the Baduanjin group, Tai Chi ball + Baduanjin group and control group, there was no significant difference (P > .05); compared with the control group, the guidance therapy group improved the left ventricular end-diastolic volume (LVEDV) index (MD = −4.67, 95%CI [−6.8, −2.71], P < .00001). In comparison, the lead group improved the 6 MWT (MD = 69.44, 95%CI [30.12, 108.76], P < .00001); the SF-36 score (MD = 10.05, 95%CI [8.68, 11.42], P < .00001])and the SAQ score (MD = 6.2, 95%CI [3.97, 8.44], P < .00001). Among the secondary outcome measures, the incidence of adverse events was statistically significant (RR = 0.17, 95%CI [0.1, 0.32], P < .00001); statistically significant (RR = 0.29, 95%CI (0.1, 0.87), P < .00001); readmission (RR = 0.39, 95%CI [0.17, 0.87, 0.89], P < .00001). CONCLUSION: Based on the current study, combining conventional therapy/ exercise or using simple lead therapy after PCI can improve the treatment effect and improve the quality of life. |
format | Online Article Text |
id | pubmed-10681617 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-106816172023-11-24 The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis Sun, Meixia Ding, Yi Chen, Kang He, Yanwen Zhang, Yukun Zhuo, Yue Zhuang, He Medicine (Baltimore) 3200 OBJECTIVE: To systematically evaluate the effects of lead therapies on percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI). METHODS: A randomized controlled trial (RCT) in the CNKI, Wanfang, VIP, ProQuest, PubMed, Cochrane Library, Scopus, and Web of Science databases was searched until January 2023. Two researchers strictly screened and checked the included literature, extracted relevant data, and used the Cochrane Manual to assess the risk quality of the literature. Using RevMan 5.3 software, Meta-analysis of 4 main outcome measures [cardiac function-related indicators, 6-minute walking distance (6 MWT), quality of life (SF-36), Seattle angina pectoris scale (SAQ)], and 3 secondary outcome measures [adverse event incidence, death incidence, and readmission rate]. RESULTS: 22 studies were finally included with 1754 subjects, but the overall quality of the included studies was not high. The results of the meta-analysis showed that, in the cardiac function-related indicators compared to controls, improved left ventricular ejection fraction (LVEF) index (MD = 1.42, 95%CI [−0.94, 3.79], P < .00001); however, compared with the Baduanjin group, Tai Chi ball + Baduanjin group and control group, there was no significant difference (P > .05); compared with the control group, the guidance therapy group improved the left ventricular end-diastolic volume (LVEDV) index (MD = −4.67, 95%CI [−6.8, −2.71], P < .00001). In comparison, the lead group improved the 6 MWT (MD = 69.44, 95%CI [30.12, 108.76], P < .00001); the SF-36 score (MD = 10.05, 95%CI [8.68, 11.42], P < .00001])and the SAQ score (MD = 6.2, 95%CI [3.97, 8.44], P < .00001). Among the secondary outcome measures, the incidence of adverse events was statistically significant (RR = 0.17, 95%CI [0.1, 0.32], P < .00001); statistically significant (RR = 0.29, 95%CI (0.1, 0.87), P < .00001); readmission (RR = 0.39, 95%CI [0.17, 0.87, 0.89], P < .00001). CONCLUSION: Based on the current study, combining conventional therapy/ exercise or using simple lead therapy after PCI can improve the treatment effect and improve the quality of life. Lippincott Williams & Wilkins 2023-11-24 /pmc/articles/PMC10681617/ /pubmed/38013356 http://dx.doi.org/10.1097/MD.0000000000036183 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | 3200 Sun, Meixia Ding, Yi Chen, Kang He, Yanwen Zhang, Yukun Zhuo, Yue Zhuang, He The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis |
title | The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis |
title_full | The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis |
title_fullStr | The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis |
title_full_unstemmed | The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis |
title_short | The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis |
title_sort | therapeutic efficacy of guided therapy for pci after acute myocardial infarction: a meta-analysis |
topic | 3200 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681617/ https://www.ncbi.nlm.nih.gov/pubmed/38013356 http://dx.doi.org/10.1097/MD.0000000000036183 |
work_keys_str_mv | AT sunmeixia thetherapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis AT dingyi thetherapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis AT chenkang thetherapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis AT heyanwen thetherapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis AT zhangyukun thetherapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis AT zhuoyue thetherapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis AT zhuanghe thetherapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis AT sunmeixia therapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis AT dingyi therapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis AT chenkang therapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis AT heyanwen therapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis AT zhangyukun therapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis AT zhuoyue therapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis AT zhuanghe therapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis |